Urban Košak

发表

Treatment of canine cognitive dysfunction with novel butyrylcholinesterase inhibitor

G. Majdič, S. Gobec, S. Prpar Mihevc, 2021, Scientific reports.

Development of an in-vivo active reversible butyrylcholinesterase inhibitor

J. Kos, B. Malawska, M. Perše, 2016, Scientific Reports.

Treatment of canine cognitive dysfunction with novel butyrylcholinesterase inhibitor

Sonja Prpar Mihevc, G. Majdič, S. Gobec, 2020, Scientific Reports.

One-Pot Synthesis of β-Keto Esters and Preparation of 3-Ketopalmitoyl-CoA

Andreja Kovač, S. Gobec, Urban Košak, 2012 .

Straightforward synthesis of orthogonally protected piperidin-3-ylmethanamine and piperidin-4-ylmethanamine derivatives

S. Gobec, Urban Košak, B. Brus, 2014 .

N-alkylpiperidine carbamates as potential anti-Alzheimer's agents.

J. Kos, S. Gobec, D. Knez, 2020, European journal of medicinal chemistry.

The Magic of Crystal Structure-Based Inhibitor Optimization: Development of a Butyrylcholinesterase Inhibitor with Picomolar Affinity and in Vivo Activity.

J. Kos, N. Coquelle, J. Colletier, 2018, Journal of medicinal chemistry.

Discovery, biological evaluation, and crystal structure of a novel nanomolar selective butyrylcholinesterase inhibitor.

S. Turk, J. Kos, N. Coquelle, 2014, Journal of medicinal chemistry.

Longitudinal evaluation of a novel BChE PET tracer as an early in vivo biomarker in the brain of a mouse model for Alzheimer disease

M. Sastre, J. Llop, P. Ramos-Cabrer, 2021, Theranostics.

Development of potent reversible selective inhibitors of butyrylcholinesterase as fluorescent probes

M. Zorović, N. Coquelle, J. Colletier, 2020, Journal of enzyme inhibition and medicinal chemistry.

Convenient syntheses of orthogonally protected aminocyclopentitols from aldopentoses

S. Gobec, M. Hrast, D. Knez, 2015 .

Synthesis and Initial Characterization of a Reversible, Selective 18F-Labeled Radiotracer for Human Butyrylcholinesterase

M. Decker, S. Gobec, D. Knez, 2021, Molecular Imaging and Biology.

Dual inhibitors of cholinesterases and monoamine oxidases for Alzheimer's disease.

M. Sova, S. Gobec, D. Knez, 2017, Future medicinal chemistry.

N-Propargylpiperidines with naphthalene-2-carboxamide or naphthalene-2-sulfonamide moieties: Potential multifunctional anti-Alzheimer's agents.

J. Kos, N. Coquelle, J. Colletier, 2017, Bioorganic & medicinal chemistry.

Structure of recombinant human butyrylcholinesterase in complex with a coumarin-based fluorescent probe linked to sulfonamide type inhibitor.

M. Zorović, N. Coquelle, J. Colletier, 2020 .